Bonellia macrocarpa
Bonellia macrocarpa · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Bonellia macrocarpa is a botanical species that has garnered scientific interest due to its potential therapeutic applications. Recent studies have specifically investigated its antiproliferative activities against various malignant cell lines. Research focuses on the efficacy of aqueous extracts derived from the plant's leaves, roots, and stems. These investigations are particularly significant in the context of developing new treatments for prostate cancer. Understanding these bioactive properties may pave the way for future pharmacological advancements.
- Synonyms
- Jacquinia Macrocarpa
- Common names
- Not available
- Family
- Primulaceae
- Distribution
- Europe
- Plant Parts
- Leaf · Root
Classification
Common Names
Bonellia macrocarpa is a plant recognized by a diverse array of regional identifiers. Depending on the local culture, it is frequently referred to by the common name Amole. In other areas, enthusiasts and locals may instead call the species San Juan. The plant also carries the distinct names Tuliviejo and chacsic within specific communities. Finally, it is sometimes known simply as corpus, reflecting the many linguistic layers tied to its identity.
Sources: Catalogue of Life (COL)
Synonyms
Bonellia macrocarpa is a botanical subject that is frequently identified by its alternative scientific designation. In many academic and horticultural circles, this plant is known by the synonym Jacquinia macrocarpa. Understanding this relationship is essential for researchers who wish to track the species across various historical botanical records. Recognizing both names ensures that botanical data remains consistent regardless of the nomenclature used. Consequently, knowing these synonyms allows for a more accurate classification of the plant's place within its genus.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Bonellia macrocarpa is a distinct botanical specimen that belongs to the kingdom Plantae. Within this vast biological realm, the plant is classified under the class Equisetopsida. Its evolutionary lineage continues through the order Ericales, showcasing its unique structural characteristics. The species is further categorized within the family Primulaceae, which helps botanists understand its close relatives. Ultimately, this plant is defined by its specific membership in the genus Bonellia.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Ericales |
| Family | Primulaceae |
| Genus | Bonellia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Bonellia macrocarpa exhibits a remarkably diverse geographic range that spans across different continents. In Asia, the species is established within the tropical regions of Indo-China and Vietnam. Its presence is also significant throughout North America, particularly within the varied landscapes of Mexico. This distribution includes specific coverage of Mexico Central, the Gulf region, and the Northeast. Furthermore, the plant can be found extending into the Northwest territories of Mexico, highlighting its broad adaptability.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Bonellia macrocarpa is a self-supporting species characterized by its distinct tree-like growth form. Reaching a maximum height of 10 meters, this plant provides a structured presence within its natural habitat. Its sturdy architecture allows it to stand firmly without the need for external support.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Bonellia macrocarpa serves as a rich source of bioactive compounds, most notably the alkyl catechol known as bonediol. Research indicates that bonediol exhibits significant antiproliferative activity by inhibiting the growth of various human prostate tumor cell lines. This compound demonstrates a capacity to bind to both estrogen receptors, effectively displacing native ligands in a manner that suggests complex hormonal interactions. Furthermore, its ability to activate detoxification enzymes through the Nrf2-ARE pathway highlights a multifaceted biological impact. Ultimately, these findings suggest that extracts from this Mayan medicinal plant may hold great promise as potential chemopreventive treatments for prostate cancer.
Compounds
Conditions
Bonellia macrocarpa exhibits significant biological potential through its various medicinal applications. The plant's stem and root bark extracts demonstrate prominent cytotoxic activity against the KB nasopharynx carcinoma cell line. Furthermore, aqueous extracts of the species display antimicrobial properties, specifically showing effectiveness against a pathogenic fungus. Research also indicates that Bonellia macrocarpa is positive against two types of pathogenic plant fungi. Finally, the isolated compound bonediol from this plant serves as a potential therapeutic treatment for prostate cancer by inhibiting the growth of human prostate tumor cells.
Preparations
Bonellia macrocarpa is prepared as aqueous extracts to evaluate its potential biological activities. These specific preparations were tested for their antimicrobial properties against human pathogenic fungi. Furthermore, the aqueous extracts of this species demonstrated effectiveness against two types of pathogenic plant fungi. This method of preparation allows researchers to explore the plant's biotechnical potential in various industries. Consequently, the use of aqueous extracts from Bonellia macrocarpa serves as a key component in assessing its medicinal value.
Parts used
Bonellia macrocarpa is a native plant species of the Yucatan coast that possesses several distinct morphological components, including the leaf, stem, and root. Research into its biological properties has revealed that aqueous extracts from this plant exhibit antimicrobial activity against specific pathogenic fungi. Furthermore, investigations into Mayan traditional medicine have highlighted the medicinal potential of its various parts. Specifically, extracts derived from the stem and root bark of the plant have demonstrated prominent cytotoxic activity against KB cancer cell lines. These findings suggest that the different anatomical structures of Bonellia macrocarpa hold significant promise for future pharmaceutical and agricultural applications.